$2.24 Billion is the total value of Vivo Capital, LLC's 59 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 26.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | $363,768,000 | +128.4% | 4,220,048 | 0.0% | 16.23% | +76.4% | |
| ASND | Ascendis Pharma A/Ssponsored adr | $299,828,000 | +8.1% | 1,797,745 | 0.0% | 13.38% | -16.5% | |
| HRMY | Harmony Biosciences Holdings Inc | $163,916,000 | +6.6% | 4,534,341 | 0.0% | 7.32% | -17.7% | |
| TARS | New | Tarsus Pharmaceuticals Inc | $134,117,000 | – | 3,245,035 | +100.0% | 5.98% | – |
| NFH | New Frontier Health Corp | $122,980,000 | +12.7% | 14,300,000 | 0.0% | 5.49% | -13.0% | |
| ALGS | New | Aligos Therapeutics Inc | $98,075,000 | – | 3,547,030 | +100.0% | 4.38% | – |
| GTH | Genetron Holdings Ltdads | $88,758,000 | +17.3% | 6,339,860 | 0.0% | 3.96% | -9.5% | |
| AMRS | Buy | Amyris, Inc | $81,274,000 | +111.5% | 13,161,847 | +0.0% | 3.63% | +63.3% |
| LEGN | Sell | Legend Biotech Corp Sponsoredsponsored ads | $77,581,000 | -24.5% | 2,755,007 | -17.3% | 3.46% | -41.7% |
| OLMA | New | Olema Pharmaceuticals Inc | $59,551,000 | – | 1,238,575 | +100.0% | 2.66% | – |
| ISEE | Iveric Bio Inc | $41,229,000 | +22.5% | 5,966,527 | 0.0% | 1.84% | -5.4% | |
| SVA | Sinovac Biotech Ltd. | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 1.70% | -22.8% | |
| PASG | Sell | Passage Bio Inc | $38,024,000 | +32.3% | 1,487,038 | -32.1% | 1.70% | +2.2% |
| CRNX | Buy | Crinetics Pharmaceuticals Inc | $32,959,000 | -7.1% | 2,335,889 | +3.2% | 1.47% | -28.2% |
| NKTX | Nkarta Inc | $31,486,000 | +104.5% | 512,225 | 0.0% | 1.40% | +57.9% | |
| KALV | Buy | KalVista Pharmaceuticals Inc. | $30,731,000 | +65.3% | 1,618,296 | +9.6% | 1.37% | +27.7% |
| SRRA | Sierra Oncology, Inc | $30,731,000 | +50.2% | 1,917,074 | 0.0% | 1.37% | +16.0% | |
| ARQT | Sell | Arcutis Biotherapeutics Inc | $24,393,000 | -25.2% | 867,170 | -22.1% | 1.09% | -42.2% |
| KDMN | Buy | Kadmon Holdings Inc | $24,142,000 | +16.4% | 5,817,459 | +9.9% | 1.08% | -10.2% |
| ZLAB | Buy | Zai Lab Ltd ADRadr | $23,685,000 | +133.2% | 175,000 | +43.3% | 1.06% | +80.1% |
| AVDL | Avadel Pharmaceuticals PLCadr | $23,554,000 | +32.5% | 3,526,093 | 0.0% | 1.05% | +2.3% | |
| CLDX | Sell | Celldex Therapeutics Inc | $22,634,000 | -11.4% | 1,291,875 | -25.0% | 1.01% | -31.6% |
| EPIX | Buy | Essa Pharma Inc | $22,594,000 | +115.9% | 1,893,907 | +24.9% | 1.01% | +66.6% |
| EIGR | Eiger BioPharmaceuticals Inc | $22,015,000 | +51.0% | 1,791,257 | 0.0% | 0.98% | +16.5% | |
| VRNA | Verona Pharma PLC ADRads | $21,340,000 | +12.2% | 3,048,507 | 0.0% | 0.95% | -13.4% | |
| ZGNX | Buy | Zogenix Inc | $20,120,000 | +37.2% | 1,006,494 | +23.1% | 0.90% | +5.9% |
| KDNY | New | Chinook Therapeutics Inc | $19,131,000 | – | 1,206,266 | +100.0% | 0.85% | – |
| NVAX | Sell | Novavax Inc | $17,561,000 | -1.3% | 157,487 | -4.1% | 0.78% | -23.7% |
| KURA | Sell | Kura Oncology Inc | $17,155,000 | -46.7% | 525,262 | -50.0% | 0.77% | -58.8% |
| LRMR | Larimar Therapeutics Inc | $17,121,000 | +41.1% | 799,662 | 0.0% | 0.76% | +9.0% | |
| RCKT | Sell | Rocket Pharmaceuticals Inc | $17,032,000 | -13.4% | 310,584 | -63.9% | 0.76% | -33.2% |
| AKRO | Buy | Akero Therapeutics Inc | $16,342,000 | -7.2% | 633,426 | +10.8% | 0.73% | -28.4% |
| IMVT | Sell | Immunovant Inc | $16,059,000 | -56.2% | 347,662 | -66.6% | 0.72% | -66.2% |
| ARWR | Sell | Arrowhead Pharmaceuticals Inc | $15,737,000 | -36.6% | 205,091 | -64.4% | 0.70% | -51.1% |
| MREO | Sell | Mereo Biopharma Group PLCads | $15,111,000 | -7.3% | 4,220,938 | -32.1% | 0.67% | -28.5% |
| CYTK | Cytokinetics Inc | $14,546,000 | -4.0% | 700,000 | 0.0% | 0.65% | -25.9% | |
| ZYME | Sell | Zymeworks Inc | $13,519,000 | -54.7% | 286,064 | -55.3% | 0.60% | -65.0% |
| CRIS | New | Curis Inc | $11,466,000 | – | 1,400,000 | +100.0% | 0.51% | – |
| ACRS | Aclaris Therapeutics, Inc. | $10,657,000 | +151.8% | 1,647,214 | 0.0% | 0.48% | +94.3% | |
| CALT | Sell | Calliditas Therapeutics ADRsponsored ads | $10,457,000 | -24.9% | 311,030 | -46.4% | 0.47% | -41.9% |
| PSTX | Sell | Poseida Therapeutics Inc | $10,163,000 | +23.7% | 926,447 | -0.0% | 0.45% | -4.4% |
| FIXX | Homology Medicines, Inc. | $9,632,000 | +5.5% | 853,143 | 0.0% | 0.43% | -18.6% | |
| MTNB | Sell | Matinas Biopharma Hldgs Inc | $8,774,000 | +1.6% | 6,451,612 | -42.8% | 0.39% | -21.4% |
| CDXS | Sell | Codexis, Inc | $8,473,000 | -51.1% | 388,144 | -73.7% | 0.38% | -62.3% |
| TXG | New | 10X Genomics Inc | $8,351,000 | – | 58,977 | +100.0% | 0.37% | – |
| AUPH | Aurinia Pharmaceuticals Inc. | $6,925,000 | -6.1% | 500,732 | 0.0% | 0.31% | -27.5% | |
| DYN | Dyne Therapeutics Inc | $6,615,000 | +4.0% | 315,000 | 0.0% | 0.30% | -19.8% | |
| ORTX | Orchard Therapeutics plcads | $5,727,000 | +5.1% | 1,325,736 | 0.0% | 0.26% | -18.7% | |
| KALA | Kala Pharmaceuticals, Inc. | $5,335,000 | -9.6% | 786,883 | 0.0% | 0.24% | -30.2% | |
| CNST | Constellation Pharmaceutical | $4,041,000 | +42.2% | 140,298 | 0.0% | 0.18% | +9.8% | |
| ATRC | Atricure Inc | $3,595,000 | +39.6% | 64,573 | 0.0% | 0.16% | +7.4% | |
| CBAY | Sell | Cymabay Therapeutics Inc | $3,360,000 | -77.8% | 585,394 | -72.0% | 0.15% | -82.8% |
| OVID | Ovid Therapeutics Inc | $2,888,000 | -59.7% | 1,250,000 | 0.0% | 0.13% | -68.9% | |
| IGMS | Sell | IGM Biosciences Inc | $1,766,000 | -76.9% | 20,000 | -80.7% | 0.08% | -82.1% |
| VYNE | Sell | VYNE Therapeutics Inc | $1,484,000 | -50.9% | 939,513 | -48.4% | 0.07% | -62.3% |
| TCDA | Tricida, Inc. | $1,232,000 | -22.2% | 174,763 | 0.0% | 0.06% | -39.6% | |
| DTIL | Precision Biosciences Inc | $1,170,000 | +35.4% | 140,255 | 0.0% | 0.05% | +4.0% | |
| MTCR | Metacrine Inc | $1,151,000 | -23.0% | 146,426 | 0.0% | 0.05% | -40.7% | |
| RVMD | Sell | Revolution Medicines Inc | $661,000 | -80.9% | 16,690 | -83.2% | 0.03% | -85.5% |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -947,175 | -100.0% | -0.14% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -816,956 | -100.0% | -0.15% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -206,225 | -100.0% | -0.16% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -145,417 | -100.0% | -0.25% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -183,042 | -100.0% | -0.27% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -300,000 | -100.0% | -0.32% | – |
| CVAC | Exit | CUREVAC N V | $0 | – | -169,825 | -100.0% | -0.46% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -5,118,560 | -100.0% | -0.72% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -1,151,622 | -100.0% | -1.02% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -158,310 | -100.0% | -1.25% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -353,511 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.